Scrapie is a transmissible, neuro-degenerative disease which occurs naturally in sheep and goats. One of the characteristics of scrapie is that a proteinase-resistant abnormal isoform of a host-encoded cellular membrane protein, referred to as prion protein (prpSc), accumulates in the central nervous system (CNS) and lymphoid tissues of sheep during the disease (Rubenstein et al., 1987; Ikegami et al., 1991) . PrP s° is thought to be derived from the normal cellular membrane protein (PrP c) by an unknown post-translational modification that probably occurs at the plasma membrane or along an endocytic pathway to the lysosomes (Caughey & Raymond, 1991) . The exact nature of the scrapie agent is still controversial; the association of PrP s~ with highly purified infectious preparations suggests that the scrapie agent is composed largely, if not entirely, of PrP s~ (Bolton et al., 1982) .
Oral/alimentary transmission is proposed as a mode of infection of some of the transmissible spongiform encephalopathies (TSEs) such as bovine spongiform encephalopathy (Wilesmith et al., 1988) , transmissible mink encephalopathy (Hartsough & Burger, 1965) and kuru (Alpers, 1987) . Oral/alimentary transmission has also been suggested as a mode for the natural spread of scrapie in sheep (Hadlow et al., 1982) , but the source of the scrapie infectivity is unclear. In addition, the sequence of events in the infectious process such as the site of entry *Author for correspondence. Fax +81 155 49 5402. and primary multiplication, and the mechanism by which the agent is transported to the CNS remain obscure. Despite relatively low titres, scrapie infectivity can be detected in non-neuronal tissues (Hadlow et al., 1982) , and PrP sc is also found in non-neuronal tissues of scrapie-infected sheep (Ikegami et al., 1991) . PrP c is considered to be a substrate for the production of scrapie infectivity (Btieler et al., 1993) , and therefore the tissue distribution of PrP c in sheep may help to understand how the infectivity spreads in the course of natural infection.
In the hamster, PrP c is reported to be found in almost all tissues (Bendheim et al., 1992) ; however, the tissue distribution of PrP c in sheep, the natural host of scrapie, is unknown. Here we report the tissue distribution of PrP c in sheep. PrP c was present in many extracerebral tissues of sheep including the proventriculus and the abomasmn.
Four A crude membrane fraction (CMF) was prepared as described below. Samples of sheep tissue (4 g) were homogenized to 10% (w/w) in CMF buffer [0'25M-sucrose, 10 mM-Tris-HC1, pH 7"5, 2.5 mM-EDTA, 1 mMdithiothreitol (DTT), and a cocktail of protease inhibitors (1 mM-phenylmethylsulphonyl fluoride, 2 gg/ ml leupeptin, 1 lag/ml pepstatin, 1 ~tg/ml aprotinin, 2 laM-E-64 and 2 gM-bestatin)]. The homogenates were centrifuged at 2000 g for 15 rain, and the supernatants were centrifuged at 100000g for 1 h. The resulting pellets were solubilized with 2 ml of lysis buffer (1% Triton X-100, 50 mM-Tris-HC1, pH 7"5, 2.5 mM-EDTA, 150 mM-NaC1, 1 mM-DTT and the cocktail of protease inhibitors), and the solutions were centrifuged at 100000 g for 1 h. The resulting supernatants were used as the Triton X-100 solubilized fractions of the CMF (TX-CMF). All procedures were done at 4 °C. To obtain the prpC-enriched fractions, TX-CMF from brain was partially purified by heparin affinity chromatography on an Econo-Pac heparin cartridge (Bio-Rad).
Affinity purified B-103 rabbit antibodies (5 lag) were added to 1 g tissue equivalent of TX-CMF and incubated for 4 h at 4 °C. The immune-complexes adsorbed by protein A-Sepharose (Pharmacia) were solubilized in 100 ~tl of sample buffer (2% SDS, 0'5 M-fl-mercaptoethanol, 10% glycerol, 0.01% bromophenol blue, 50 mM-Tris-HC1, pH 6.8). The proteins were subjected to SDS-12.0% polyacrylamide gel electrophoresis (PAGE), and transferred electrophoretically to nitrocellulose membranes. The blots were visualized with ECL Western blotting detection reagents (Amersham).
Total RNA was extracted from sheep tissues by using an acid guanidinium thyocyanate-phenol-chloroform method (Chomczynski & Sacchi, 1987) . Poly(A) + RNA Was purified with Oligotex-dT 30 (Takara). Electrophoresis and transfer of RNA to nylon membranes were performed as described by Sambrook et al. (1989) . Amino acid polymorphisms were determined by DNA sequencing of PCR-amplified sheep PrP DNA as described elsewhere (Ikeda et al., 1995) .
Hybridomas BSPX-54 and B-225-101, which secreted MAbs against synthetic peptides B-146 and B-225, respectively, were established. No MAb against synthetic peptide B-103 was obtained. First, we tried to detect PrP c directly in the TX-CMF of various sheep tissues by Western blot analysis; however, PrP c was detected only in the CNS (data not shown). N e x t we tried to detect PrP c by immunoprecipitation followed by Western blot analysis. A combination of B-103 rabbit antibodies for immunoprecipitation and MAb B-225-101 for immuno-staining was the best of several combinations of antibodies tested. Thus, this combination was used in the following analysis. The use of two antibodies which recognize different epitopes in PrP c made it possible to produce reliable results. Fig. 2 shows the distribution of PrP c in various sheep tissues. When 200 mg tissue equivalent of immunoprecipitate was used for the analysis, PrP c was detected in the cerebrum, spleen, lung, adrenal gland, lymph node, uterus, heart, skeletal muscle and parotid gland (sheep I, Blue-de-Dorset; PrP genotype, Prp~A~Q/ Prp~v~q). No PrP c was detected in the pancreas, liver and kidney. No band was detected when immunoprecipitation was performed with normal rabbit IgG instead of B-103 rabbit IgG (data not shown). To examine the distribution of PrP c further, we analysed another sheep (sheep II, Suffolk; PrP genotype, PrWARQ/ PrpMARR). Similar to sheep I, PrP c was detected in many non-neuronal tissues. PrP c was detected in the kidney but only when 400 mg of kidney equivalent was used (data not shown). PrP c was not detected in the liver and pancreas even when 400 mg tissue equivalent was used. PrP c was also detected in the rumen, reticulum, omasum and abomasum (sheep III, Suffolk; PrP genotype, PrpMARQ/PrPMA~). However, some differences in the distribution ofPrP c were observed in sheep III: PrP c was not detected in the adrenal gland and lymph node, and the molecular mass of PrP c in the spleen of sheep III (20-26 kDa) was less than in other sheep. This band was still detected by immunostaining with MAb BSPX-54 (data not shown). In addition, heterogeneity of PrP c was observed among tissues and among sheep. We do not have any evidence to explain the heterogeneity; it is conceivable that the composition of oligosaccharide chains differs among the cell types or that the PrP genotype also affects the biochemical properties of PrP c; however, further analysis is required to assess these possibilities. PrP c was also detected in mammary gland (data not shown).
As described above, PrP c was not detected in liver and pancreas. To examine whether PrP mRNA was expressed in these tissues, Northern blot analysis was performed. As shown in Fig. 3 , an m R N A of about 4-1 kb was detected in all tissues except for liver and pancreas. In addition to a 4.1kb mRNA, a 2.1kb mRNA was detected in kidney, spleen, lung, adrenal gland, lymph (Fig. 3) . On the other hand, PrP c was detected in 0.5 mg brain equivalent of TX-CMF, but not at all in the kidney even when 20 mg tissue equivalent of T X -C M F was used, indicating that the brain contains at least fortyfold more PrP c than the kidney (data not shown). Thus, the translational efficiency or the course of PrP c synthesis including degradation may differ between the brain and the other cell types that express PrP c. In this paper, we have shown that PrP c is present in many non-neuronal tissues of sheep. Widespread distribution of PrP c in hamsters has also been reported (Bendheim et al., 1992) , indicating that the pattern of distribution seems to be basically comparable among mammals. Quantitative comparison of this distribution could not be done because of the differences in the antibodies used. An apparent difference was observed in PrP m R N A expression: the PrP m R N A in mice and hamster spleens was less than 1% of that in the brain (Caughey et al., 1988) , while PrP m R N A in sheep spleen was estimated to about 10 % of that in the brain (Fig. 3) . Divergence between the sheep and rodent PrP gene promoter regions (Westaway et al., 1994 ) may explain this difference. Expression of PrP m R N A , therefore, is not likely to be comparable between sheep and rodents. PrP c is reported to be involved in long term potentiation in the hippocampus (Collinge et al., 1994) ; however, the occurrence of PrP c in nearly all tissues suggests that the normal function of PrP c is not unique to neuronal tissues.
Although the conditions under which the conversion of PrP c to PrP sc occurs remain to be elucidated, the existence of a substrate for PrP s° in a variety of tissues indicates that PrP s° may be produced in many tissues; the scrapie agent might potentially be able to replicate in a variety of tissues. The high infectivity in the CNS and low infectivity in the liver of scrapie-affected sheep or goats, and BSE-affected cattle (Hadlow et af., 1979; Danner, 1993) , agree well with the distribution of prpc; however, the distribution of PrP c in non-neuronal tissues appeared to be inconsistent with the tissue distribution of infectivity reported so far. For instance, infectivities in the heart and skeletal muscles have been reported to be undetectable (Hadlow et al., 1979; Danner, 1993) , whereas PrP c was apparently present in these tissues. This may indicate that factor(s) specific to certain cell types are required for the multiplication of scrapie infectivity; or possibly, the scrapie agent may not reach the heart and skeletal muscle during the course of infection. Comparison of the cells expressing PrP c with those in which PrP s~ accumulates should help to resolve this question. Furthermore, such information and the sensitive PrP detection method described here will greatly contribute to the improvement of pre-clinical diagnosis (Ikegami et al., 1991) .
